Current Issues in Immunisation Against Hepatitis A and B
Infection with hepatitis A and hepatitis B viruses is a major public health problem. The development and availability of safe and immunogenic vaccines, which have been shown to be highly effective, constitute a major advance in preventive medicine. Several current issues of practical importance are reviewed below.
KeywordsHepatitis Europe Glycine Adenosine Syringe
Unable to display preview. Download preview PDF.
- Lemon SM, Stapleton JT (1997) Prevention of hepatitis A. In: Zuckerman AJ, Thomas HC (eds) Viral hepatitis: scientific basis and clinical management, 2nd edn. Churchill Livingstone, Edinburgh (in press)Google Scholar
- Tedder RS, Zuckerman MA, Brink N (1993) Hepatitis B vaccination: non-responders must be detected. Lancet 307:732Google Scholar
- WHO (1983) Prevention of liver cancer. WHO Tech Rep Ser 691Google Scholar
- Zuckerman AJ (ed) (1996) Prevention of hepatitis B in the newborn, children and adolescents. Royal College of Physicians, LondonGoogle Scholar